Osimart 80mg Tablet – Targeted Therapy for Lung Cancer

Osimart 80mg Tablet contains Osimertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor used for the treatment of non-small cell lung cancer (NSCLC). It is specifically designed for patients with EGFR T790M mutation-positive NSCLC or as a first-line treatment for metastatic EGFR-mutated NSCLC.

Key Features & Benefits:

✔ Precision Targeted Therapy – Inhibits mutated EGFR to slow or stop cancer growth
✔ Advanced NSCLC Treatment – Effective against T790M mutation-positive lung cancer
✔ Enhanced Survival Outcomes – Helps improve progression-free survival rates
✔ Convenient Oral Tablet – Easy-to-take daily dose

Dosage & Administration:

• The typical recommended dose is 80mg once daily, or as prescribed by a healthcare professional.
• Can be taken with or without food.

Precautions & Warnings:

• Should only be used under medical supervision.
• Not recommended for use in pregnant or breastfeeding women unless advised by a doctor.
• Regular monitoring of lung and heart function may be required.
• Inform your doctor about any other medications or pre-existing conditions before use.

Storage:

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Note: Osimart 80mg Tablet is a prescription-only medication and should be used strictly as directed by a healthcare professional.

Always consult your doctor before starting or changing any medication.